THE PROBLEM

Half the world’s adult population are at risk of cardio-renal-metabolic disease

For decades, the term metabolic syndrome described a clustering of abdominal obesity, insulin resistance, dyslipidemia, and hypertension.

Today, science recognizes this cluster not as an isolated condition, but as an early expression of a broader, interconnected disease network.

Current treatments are imprecise "one-size-fits-all" medicines

OUR Approach

We seek to transform the lives of patients with complex age-related chronic diseases who do not respond to current treatments

We use AI to uncover clinically meaningful patient subpopulations and predict disease progression. By identifying high-risk patients early and matching them with the most effective therapies, we enable earlier intervention, improve outcomes, and drive more efficient use of healthcare resources

PRECISION THERAPEUTICS FOCUS THE RIGHT TREATMENT ON THE RIGHT PATIENT

how we DO IT

A PLATFORM generating precision INSIGHTS & programs.

MOH’s platform is built on uniquely curated patient datasets that combine longitudinal medical records with multi-omics data generated from patient samples. Our proprietary AI-driven time-series analytics identify and predict patient endotypes, providing the foundation for discovering targeted therapeutic and diagnostic opportunities.

IMPACT.

IMPACT #1

ENDOTYPES + PSM

Impact of our renal endotyping and patient-stratifying models (PSM) when optimized and implemented as diagnostic products (SaMD, IVD)

IMPACT #2

TARGETS + CDx

Impact of our patient-stratified renal drug targets with companion diagnostics (CDx) when implemented as precision medicines

Data-DRIVEN THERAPEUTICS FOR WORLD'S #1 HEALTH PROBLEM

Contact.

Want to be a part of our team?

Got a partnership in mind?

Get in touch with us and know more about how we are changing the face of healthcare.

THE COMPANY

Multiomic Health Limited is a registered UK company

Company #13246608

EMAIL US

info@multiomic.health

Connect

COPYRIGHT notice

All the content on multiomic.health is either self-generated by Multiomic Health Limited, or readily available in various places on the Internet and therefore believed to be in the public domain. Transparent PNG images uploaded are believed to be posted within our rights according to the U.S. Copyright Fair Use Act (Title 17, U.S. Code.) and comparable regulations in other countries.

multiomic.health complies with 17 U.S.C. 512 and the Digital Millennium Copyright Act (“DMCA”). It is our policy to respond to any infringement notices and take appropriate actions under the DMCA and other applicable intellectual property laws.

If by any chance your copyrighted material has been posted on multiomic.health or if links to your copyrighted material are returned through a search engine and you wish this material removed, please provide a written statement identifying in sufficient detail the copyrighted work claimed to have been infringed. You may use the contact form at the end of the landing page for the purposes of such written communication.

DATA SOURCES

https://ourworldindata.org/causes-of-death

https://ourworldindata.org/obesity

https://bmjopen.bmj.com/content/10/8/e036663

How Prevalent is NASH?

https://www.heart.org/-/media/phd-files-2/science-news/2/2021-heart-and-stroke-stat-update/2021_heart_disease_and_stroke_statistics_update_fact_sheet_at_a_glance.pdf?la=en

https://www.ahajournals.org/doi/10.1161/CIR.0000000000000757

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278808/

https://www.cdc.gov/obesity/data/adult.html

https://stop.publichealth.gwu.edu/sites/stop.publichealth.gwu.edu/files/documents/Fast%20Facts%20Cost%20of%20Obesity.pdf

https://www.sciencedirect.com/science/article/abs/pii/S2211883717300187

https://journals.lww.com/jcge/Abstract/2015/09000/The_Epidemiology_of_Cirrhosis_in_the_United.12.aspx#:~:text=The%20prevalence%20of%20cirrhosis%20in%20the%20United%20States%20was%20approximately,unaware%20of%20having%20liver%20disease

How Prevalent is NASH?

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743497/#:~:text=In%20the%20United%20States%2C%20NAFLD,nearly%2025%25%20progress%20to%20NASH

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767767/

https://www.nature.com/articles/nrgastro.2017.109

https://www.diabetes.org/resources/statistics/statistics-about-diabetes#:~:text=Prevalence%3A%20In%202018%2C%2034.2%20million,of%20the%20population%2C%20had%20diabetes.&text=Undiagnosed%3A%20Of%20the%2034.2%20million,and%207.3%20million%20were%20undiagnos

https://www.kcl.ac.uk/news/spotlight/global-cost-of-diabetes-set-to-double-by-2030

https://www.kcl.ac.uk/news/spotlight/global-cost-of-diabetes-set-to-double-by-2030

https://www.worldobesity.org/news/world-obesity-day-all-countries-significantly-off-track-to-meet-2025-who-targets-on-obesity